Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Tyra Biosciences Inc fell by 193.21m. Cash Flow from Financing totalled 1.54m or -- of revenues. In addition the company used 50.14m for operations while cash used for investing totalled 144.61m.
Cash flow per share | -1.57 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 6.85 |
---|---|
Tangible book value per share | 6.85 |
More ▼
Balance sheet in USDView more
Current ratio | 29.55 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼